Full Text (PDF)
Review Article

Ebola Hemorrhagic Fever

Dalip K Kakru , Dalip K Kakru , Mohd Suhail , Nargis Bali , Junaid Ahmad , Humaira Bashir

Author Information

Licence:




Journal of Microbiology and Related Research 1(1):p 29-35, January - June 2015. | DOI:

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Ebola virus disease (EVD) also known as Ebola haemorrhagic fever is a severe contagious disease affecting humans and non-human primates. It is usually transmitted to humans through direct contact with blood, tissue, body fluids and secretions from an infected animal or human. The causative agent is classified in the genus Ebolavirus of the Filoviridae family. Filoviruses are filamentous enveloped viruses containing a non-segmented, negative-strand genomic RNA of approximately 19 kilobases. Patients are diagnosed by testing of body fluids and serum with an ELISA test/ PCR; however the results are not always accurate. There is currently no treatment for Ebola hemorrhagic fever. Vaccines are in clinical trials and hold the future in preventing this disease. Ebola is on the United States’ list of possible bioterrorism agents because no humans have been found to have immunity to it. 

 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Monday 21 September 2026, 14:27:58 (IST)


1469

Accesses

2
188
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share